View Printer-Friendly PDF

A Life Sciences Canada Profile

Aequus Pharmaceuticals Inc

2820-200 Granville St
Vancouver BC  V6C 1S4
Canada

  • Tel: 604-336-7906
  • CEO: Doug Janzen
  • COO: Anne Stevens
  • CSO: Donald McAfee
  • Bus Dev: Ian Ball
  • Est: 2013 - Public
  • Rev: $1–5 M
  • Staff: 10–50
  • CNS/Neurology
  • Ophthalmology
  • Transplantation
  • Research & Dev.
  • Product Development
  • Product Licence
  • Partnership
  • Business Development
  • Commercialization
  • Drug Delivery

Aequus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus’ sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including neurology, ophthalmology and transplant. Aequus intends to commercialize its internal programs in Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide.

Mfg: No   Labs: No

TSX-V: AQS

0.0114